Barnes Reports | 163 pages | Octobre 2006 | Anglais
The Medical Laboratories Industry report features 2007 current and 2008 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and ...
IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's October 2007 edition of Child Care Services in Australia report.Industry Market Research SynopsisThis Industry Market R ...
The ``Sector Snapshot`` is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot details the Chinese i ...
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the ...
Snapshots International | 17 pages | Décembre 2004 | Anglais
Snapdata's US Prescription Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US prescription p ...
IntroductionThis analysis examines the current position and future outlook for Merck KGaA in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeli ...
Global Industry Analyst | 387 pages | Octobre 2006 | Anglais
This report analyzes the worldwide markets for Colorectal Cancer Therapeutics in US$ Million. The major product segments analyzed are Cytotoxic Therapies (5-FU (Fluorouracil), Camptosar (Irinotecan ...
The range of conditions within cardiovascular disease is wide, although the basic etiology of cardiovascular disease is generally well understood the focus on treatment in cardiovascular disease is tw ...
IBISWORLD INDUSTRY MARKET RESEARCH REPORTThis is the replacement for IBISWorld's November 2006 edition of Pharmaceutical Goods Retailing in Australia report.Industry Market Research SynopsisThis Indus ...
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand ...